Investing in Regenerative Medicine (RM)

By Paul Ebeling on April 19, 2017   Headline News, Health, Investments, Opinion, OTC Markets, Paul Ebeling, Paul Ebeling, Stocks, Top Stories, US Stocks  

Investing in Regenerative Medicine (RM) $GS, $BTX A recent report from Goldman Sachs (NYSE:GS) includes a section titled “The Coming Age of Regenerative Medicine.” An article about the report in BI is titled “Money is pouring in to a hot new area of science that could change the way we think about aging.” According to […]